Our results showed that PVP-I can inhibit the inflammation-induced IL-1β secretion and IRF3/7 activation, and 27 cytokines in airway epithelial cells and pHNECs from nasal polyps (Fig. 4 and Supplementary Fig. S3). Here, IRF3 is linked to Nasal polyposis.